New eye drop trial targets fast relief for dry eye sufferers
NCT ID NCT07268599
Summary
This study is testing whether Acoltremon 0.003% eye drops can provide rapid relief from dry eye symptoms like irritation, burning, and grittiness. Researchers will track symptom changes over 28 days in 50 adults with moderate-to-severe dry eye disease. The goal is to understand how quickly this treatment can improve daily comfort for people struggling with persistent dry eye.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Colvard-Kandavel Eye Center
Encino, California, 91316, United States
Conditions
Explore the condition pages connected to this study.